Jason talks about his current work, new developments in value-based care, information sharing and big data, and the potential of non-traditional health determinants. Evolving markets do make strategy challenging, but Evolent recently showed its strategic guile by refocusing into value-based, specialty care. Indicating this market could be engaging in value addition; a concept where firms focus on separate & distinct segments and increase value for everyone.
A rare economic win/win? Listen in.